National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

About NIAID
 Who We Are and What We Do
 Organization
  Office of the Director
  DAIDS
  DAIT
  DCR
  DEA
  DIR
  DMID
  VRC
 About the Director
 Working at NIAID
 Finding People
 Visitor Information
 Employee Information


Division of Acquired Immunodeficiency Syndrome (DAIDS)

Office for Policy in Clinical Research Operations (OPCRO)

The DAIDS Office for Policy in Clinical Research Operations (OPCRO) manages and supports the DAIDS clinical research and helps ensure compliance with applicable regulations, standards, and good clinical practice guidelines; study participant safety and welfare; and study quality and integrity. OPCRO, which includes the Clinical Research Resources Branch, Human Subjects Protection Branch, Policy, Training, and Quality Assurance Branch, Regulatory Affairs Branch, Pharmaceutical Affairs Branch; Clinical Trials Agreements Team, and Safety and Pharmacovigilance Team, carries out the following key functions:

  • Develops and maintains Division-wide clinical research polices and standard procedures and coordinates related training and quality assurance activities
  • Manages a portfolio of DAIDS contracts for independent site monitoring
  • Implements the DAIDS safety monitoring and reporting, related safety standards, and pharmacovigilance capacity
  • Manages Investigational New Drug Applications
  • Provides pharmaceutical expertise
  • Develops Clinical Trial Agreements
  • Protects the rights and well-being of clinical research subjects

back to top


Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research
Nov. 3, 2009

Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009
Oct. 15, 2009

National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009
Sept. 25, 2009

HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study
Sept. 24, 2009

Special Announcements

  • Status of NIAID Adenovirus-based Vaccine Studies
  • Considerations for HIV Vaccine Clinical Trials in Adolescents
  • Guidance regarding HIV anti-retroviral treatment in developing countries
  • See Also

    HIV/AIDS



    Highlights

    Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
    Feb. 1, 2008

    News Releases

    NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research
    Nov. 3, 2009

    Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009
    Oct. 15, 2009

    National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009
    Sept. 25, 2009

    HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study
    Sept. 24, 2009

    Special Announcements

  • Status of NIAID Adenovirus-based Vaccine Studies
  • Considerations for HIV Vaccine Clinical Trials in Adolescents
  • Guidance regarding HIV anti-retroviral treatment in developing countries
  • See Also

    HIV/AIDS